​​Join us to explore the core principles that govern licensing and technology transfer within the biotech industry, including how academic inventions are evaluated, protected, and ultimately advanced through development and commercialization pathways

Our panelists will guide a conversation outlining the end-to-end technology transfer pathway – from invention disclosure and patenting decisions through license negotiation and post-license obligations, and discuss the key structures that shape these agreements. The session will emphasize practical considerations for early-stage teams seeking to align scientific development, institutional requirements, and future financing or partnering.

​Panelists: Tali Tuchin, Marc Morley, and Paul Roben

​Our panel will be followed by an unstructured networking hour from 7:00 – 8:00 pm.

We would like to thank Mintz for hosting this event!